# Damora Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:b60db625-6b5c-4453-9341-412984f8a451 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/damora-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 16 |
| Claims under review | 1 |
| Evidence records | 3 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-17T04:46:07.749004+00:00 |
| Last reviewed | 2026-10-17T04:46:07.749004+00:00 |

## Identity

- Legal name: Damora Therapeutics, Inc.
- Display name: Damora Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-17T05:44:42.534264+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.826 |
| Directors | 7 |
| Committees | 1 |
| Governance events | 6 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Cameron Turtle: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:5
- Christopher Cain: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:6
- Garrett Winslow: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:7
- Julianne Bruno: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:9
- Michael Landsittel: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:10
- Peter Harwin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:11
- Jennifer Jarrett: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:8

## Committees

- Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Jennifer Jarrett (member, unknown). committee_id=alpha:committee:damora-therapeutics-inc:chief-executive-officer-and-director

## Executive leadership

- Becker Hewes: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:12
- Garrett Winslow: General Counsel [GC]. Status: unknown. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:13
- Jennifer Jarrett: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:14
- Lori Firmani: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:15
- Sherwin Sattarzadeh: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:16

## Governance events

- DIRECTOR_APPOINTED: Garrett Winslow seat on Damora Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:134t4twbxozkq
- DIRECTOR_APPOINTED: Cameron Turtle seat on Damora Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1asisld1qo4nof
- DIRECTOR_APPOINTED: Michael Landsittel seat on Damora Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1g44t953vnk43
- DIRECTOR_APPOINTED: Christopher Cain seat on Damora Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1auk07b47cee3
- DIRECTOR_APPOINTED: Julianne Bruno seat on Damora Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1dvzg1m119i280
- DIRECTOR_APPOINTED: Peter Harwin seat on Damora Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1it5f4fefrc3l

## Scoped resources

- `alpha://company/damora-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record
- `alpha://company/damora-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=identity
- `alpha://company/damora-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/damora-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=board
- `alpha://company/damora-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=committees
- `alpha://company/damora-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=leadership
- `alpha://company/damora-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=ownership
- `alpha://company/damora-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=financials
- `alpha://company/damora-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/damora-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=compensation
- `alpha://company/damora-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=governance
- `alpha://company/damora-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/damora-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=audit
- `alpha://company/damora-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=legal
- `alpha://company/damora-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=risk
- `alpha://company/damora-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=cyber
- `alpha://company/damora-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/damora-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=agents
- `alpha://company/damora-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/damora-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=events
- `alpha://company/damora-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=relationships
- `alpha://company/damora-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=assessments
- `alpha://company/damora-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Cameron Turtle: Director. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:5. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53fe6fd71fa16b9f3d8b8ac89ec8764a874339c7a5489bb1f92bcae2c7c0bbc6.
- Christopher Cain: Director. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53fe6fd71fa16b9f3d8b8ac89ec8764a874339c7a5489bb1f92bcae2c7c0bbc6.
- Garrett Winslow: Director. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:7. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53fe6fd71fa16b9f3d8b8ac89ec8764a874339c7a5489bb1f92bcae2c7c0bbc6.
- Jennifer Jarrett: President, Chief Executive Officer and Director. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e280114e278910e2ac11b0a227c5d5597cc9c039c0d24cb3abaa8a575b1a8fa2.
- Julianne Bruno: Director. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53fe6fd71fa16b9f3d8b8ac89ec8764a874339c7a5489bb1f92bcae2c7c0bbc6.
- Michael Landsittel: Director. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:10. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53fe6fd71fa16b9f3d8b8ac89ec8764a874339c7a5489bb1f92bcae2c7c0bbc6.
- Peter Harwin: Director. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:11. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53fe6fd71fa16b9f3d8b8ac89ec8764a874339c7a5489bb1f92bcae2c7c0bbc6.
- Becker Hewes: Chief Medical Officer. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e280114e278910e2ac11b0a227c5d5597cc9c039c0d24cb3abaa8a575b1a8fa2.
- Garrett Winslow: General Counsel. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e280114e278910e2ac11b0a227c5d5597cc9c039c0d24cb3abaa8a575b1a8fa2.
- Jennifer Jarrett: President and Chief Executive Officer. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e280114e278910e2ac11b0a227c5d5597cc9c039c0d24cb3abaa8a575b1a8fa2.
- Lori Firmani: Chief Financial Officer. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e280114e278910e2ac11b0a227c5d5597cc9c039c0d24cb3abaa8a575b1a8fa2.
- Sherwin Sattarzadeh: Chief Operating Officer. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e280114e278910e2ac11b0a227c5d5597cc9c039c0d24cb3abaa8a575b1a8fa2.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Damora Therapeutics, Inc.. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bbafe12ce6f25cc1b65d0eabc4a9de52acb0b60d64b971b43eb0f87f4001c8f2.

## Entity Status

- Public listing published. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bbafe12ce6f25cc1b65d0eabc4a9de52acb0b60d64b971b43eb0f87f4001c8f2.

## Published Fact

- US. Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bbafe12ce6f25cc1b65d0eabc4a9de52acb0b60d64b971b43eb0f87f4001c8f2.

## Security Listing

- DMRA (NASDAQ). Claim: alpha:claim:company:b60db625-6b5c-4453-9341-412984f8a451:security_listing:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bbafe12ce6f25cc1b65d0eabc4a9de52acb0b60d64b971b43eb0f87f4001c8f2.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:bbafe12ce6f25cc1b65d0eabc4a9de52acb0b60d64b971b43eb0f87f4001c8f2: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/damora-therapeutics-inc).
- alpha:projection-evidence:document:53fe6fd71fa16b9f3d8b8ac89ec8764a874339c7a5489bb1f92bcae2c7c0bbc6: [DEF 14A dmra-20260429.htm](https://www.sec.gov/Archives/edgar/data/1800315/000119312526191429/dmra-20260429.htm).
- alpha:projection-evidence:document:e280114e278910e2ac11b0a227c5d5597cc9c039c0d24cb3abaa8a575b1a8fa2: [SEC DEF 14A 0001193125-26-191429](https://www.sec.gov/Archives/edgar/data/1800315/000119312526191429/dmra-20260429.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/damora-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/damora-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/damora-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/damora-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-17T05:44:42.337752+00:00; recorded 2026-10-17T05:44:42.337752+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.